These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1701682

  • 1. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
    Reid MS, Herrera-Marschitz M, Terenius L, Ungerstedt U.
    Brain Res; 1990 Sep 03; 526(2):228-34. PubMed ID: 1701682
    [Abstract] [Full Text] [Related]

  • 2. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS, Herrera-Marschitz M, Hökfelt T, Ohlin M, Valentino KL, Ungerstedt U.
    Neuroscience; 1990 Sep 03; 36(3):643-58. PubMed ID: 1700329
    [Abstract] [Full Text] [Related]

  • 3. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
    Reid MS, Hökfelt T, Herrera-Marschitz M, Håkanson R, Feng DM, Folkers K, Goldstein M, Ungerstedt U.
    Brain Res; 1990 Nov 05; 532(1-2):175-81. PubMed ID: 1704289
    [Abstract] [Full Text] [Related]

  • 4. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
    Reid MS, Herrera-Marschitz M, Ungerstedt U.
    Neuroscience; 1990 Nov 05; 36(3):659-67. PubMed ID: 1700330
    [Abstract] [Full Text] [Related]

  • 5. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
    Reid M, Herrera-Marschitz M, Hökfelt T, Terenius L, Ungerstedt U.
    Eur J Pharmacol; 1988 Mar 15; 147(3):411-20. PubMed ID: 2454197
    [Abstract] [Full Text] [Related]

  • 6. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS, Herrera-Marschitz M, Hökfelt T, Lindefors N, Persson H, Ungerstedt U.
    Exp Brain Res; 1990 Mar 15; 82(2):293-303. PubMed ID: 1704847
    [Abstract] [Full Text] [Related]

  • 7. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
    Reid MS, Herrera-Marschitz M, Ungerstedt U.
    J Neurochem; 1991 Sep 15; 57(3):970-4. PubMed ID: 1713616
    [Abstract] [Full Text] [Related]

  • 8. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U.
    Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763
    [Abstract] [Full Text] [Related]

  • 9. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
    Reid MS, Herrera-Marschitz M, Kehr J, Ungerstedt U.
    Acta Physiol Scand; 1990 Dec 11; 140(4):527-37. PubMed ID: 1707211
    [Abstract] [Full Text] [Related]

  • 10. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
    Tan DP, Tsou K.
    Brain Res; 1988 Mar 08; 443(1-2):310-4. PubMed ID: 2451993
    [Abstract] [Full Text] [Related]

  • 11. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat.
    Humpel C, Saria A.
    Neurosci Lett; 1993 Jul 23; 157(2):223-6. PubMed ID: 7694197
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
    Tan DP, Tsou K.
    J Neurochem; 1988 Nov 23; 51(5):1333-7. PubMed ID: 2459306
    [Abstract] [Full Text] [Related]

  • 13. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism.
    Humpel C, Saria A, Regoli D.
    Eur J Pharmacol; 1991 Mar 19; 195(1):107-14. PubMed ID: 1712305
    [Abstract] [Full Text] [Related]

  • 14. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N, Brodin E, Tossman U, Segovia J, Ungerstedt U.
    Exp Brain Res; 1989 Mar 19; 74(3):527-34. PubMed ID: 2468514
    [Abstract] [Full Text] [Related]

  • 15. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
    Herrera-Marschitz M, Christensson-Nylander I, Sharp T, Staines W, Reid M, Hökfelt T, Terenius L, Ungerstedt U.
    Exp Brain Res; 1986 Mar 19; 64(1):193-207. PubMed ID: 2429859
    [Abstract] [Full Text] [Related]

  • 16. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Konieczny J, Lenda T, Czarnecka A.
    Neuroscience; 2016 Jun 02; 324():92-106. PubMed ID: 26964686
    [Abstract] [Full Text] [Related]

  • 17. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
    Baruch P, Artaud F, Godeheu G, Barbeito L, Glowinski J, Chéramy A.
    Neuroscience; 1988 Jun 02; 25(3):889-98. PubMed ID: 2457187
    [Abstract] [Full Text] [Related]

  • 18. The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats.
    Boix F, Huston JP, Schwarting RK.
    Brain Res; 1992 Oct 02; 592(1-2):181-6. PubMed ID: 1280516
    [Abstract] [Full Text] [Related]

  • 19. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
    Elliott PJ, Mason GS, Stephens-Smith M, Hagan RM.
    Neuropeptides; 1991 Jun 02; 19(2):119-26. PubMed ID: 1719444
    [Abstract] [Full Text] [Related]

  • 20. Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study.
    Zetterström T, Sharp T, Ungerstedt U.
    Eur J Pharmacol; 1986 Dec 02; 132(1):1-9. PubMed ID: 3816961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.